KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Equity Ratio (2018 - 2025)

Twist Bioscience (TWST) has disclosed Equity Ratio for 6 consecutive years, with 0.82 as the latest value for Q1 2023.

  • On a quarterly basis, Equity Ratio fell 2.45% to 0.82 in Q1 2023 year-over-year; TTM through Mar 2023 was 0.82, a 2.45% decrease, with the full-year FY2022 number at 0.82, down 0.75% from a year prior.
  • Equity Ratio was 0.82 for Q1 2023 at Twist Bioscience, roughly flat from 0.82 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.91 in Q1 2021 to a low of 0.54 in Q4 2019.
  • A 5-year average of 0.81 and a median of 0.82 in 2023 define the central range for Equity Ratio.
  • Biggest YoY gain for Equity Ratio was 146.75% in 2019; the steepest drop was 36.39% in 2019.
  • Twist Bioscience's Equity Ratio stood at 0.54 in 2019, then soared by 57.25% to 0.84 in 2020, then fell by 5.52% to 0.8 in 2021, then increased by 3.09% to 0.82 in 2022, then grew by 0.4% to 0.82 in 2023.
  • Per Business Quant, the three most recent readings for TWST's Equity Ratio are 0.82 (Q1 2023), 0.82 (Q3 2022), and 0.85 (Q1 2022).